About | Free Trial

Last Update


This profile was last updated on . .

Is this you? Claim your profile.

Wrong Niranjan Kumar?

Dr. Niranjan Kumar M.

Chief Executive Officer

American Biosources Inc

American Biosources Inc

Company Description

American Biosources (ABS) Inc. is a Biopharmaceutical & Biotechnology R & D, Process Development, and Clinical stage company with few products in pipeline within the following Strategic Business Units: • Novel Vaccines (Viral, Bacterial). • Innovative B... more

Find other employees at this company (1)

Background Information

Employment History

Chairman and Chief Executive Officer

ABS Novacell LLC

Executive Director

Novavax , Inc.

Advisory Team


Senior Vice President


Senior Vice President

Biotech Companies


Executive Member
Global Bio Pharma Conference Group

Member of Board of Advisors
The Varhad Group


Ph.D. Executive Masters
Technology Management

Web References (14 Total References)

India | EEFC Energy

eefcenergy.com [cached]

Dr. Niranjan Kumar Chairman / CEO AMERICAN BIOSOURCES INC. 80 Main Street, 5th Floor, West Orange, NJ 07052, USA Email: nkumar.wharton@gmail.com

Dr. Niranjan Kumar, Chairman/CEO ABS Novacell LLC has partnered with EEFC to accomplish renewable energy projects in India in association with Suryachakra Power Corporation. Our current project - producing pellets from biomass to be used as fuel.

Global Bio Pharma Conference Group welcomes you...

www.gbpcg.com [cached]

Dr. Niranjan Kumar , Ph. D, EMTM (U PENN) CEO, American Biosources, Inc, USA & Chairman & CEO, ABS Novacell Pvt. Ltd. India

Leadership « Varhad Capital

www.varhadcapital.com [cached]

Dr. Niranjan Kumar, Ph.D. Executive Masters in Technology Management Dr. Kumar is a member of board of advisors of The Varhad Group. Dr. Kumar is currently Chairman and CEO of ABS Novacell Ltd. He has a PhD in Biochemistry & Microbiology, Executive Masters in Technology Management (Pen Eng & Wharton Business School, UPenn) and has 25 years of extensive experience in Biologics (novel vaccines) & Biotherapeutics (Proteins & Monoclonal Antibodies) & Blood Plasma Products. He has founded 2 companies in the US (American Bio Sources Inc. Innovative Biopharmaceutical Products company & ABSINCGROUP - Strategic Management Consulting & Services) and one non-profit Organization in the US (Global Bio Pharma Conference Group). Dr Kumar has held numerous senior management positions such as Senior VP, Wockhardt Biotech Strategic Business Unit, Executive Director, Novavax Inc. USA, Dy. Director in Sanofi-Aventis, Group Leader Wyeth (Pfizer, USA) and Merck & Co. Inc. USA and managed multi-billion dollars budgets, projects, P &L and people and various sites in the World. Prior to that Dr. Kumar was Asst. Professor of Medicine, Pulmonary Critical Care/Lung Biology, State University of New York, Buffalo, NY and Post Doctoral Fellow in SUNY @ Buffalo and University of Rochester Medical School, Rochester, NY. Dr. Kumar has contributed numerous block buster drugs launch and published numerous peer reviewed papers and presented in numerous International Conferences. Dr.Kumar brought US $ 200M LOI from EXIM bank for renewable energy projects.

Dr. Niranjan Kumar ...

bsm.us.com [cached]

Dr. Niranjan Kumar Ph.D. Dr. Kumar is in Biochemistry & Microbiology, Executive Masters in Technology Management (Penn Eng.

Dr. Kumar is Chairman & CEO of ABSNOVACELL LTD. and elected USP Expert committee (2005-2010) . Dr. Kumar is actively involved in business development & fund raising and held numerous senior management positions as Senior VP, Wockhardt Biotech Strategic Business Unit, responsible for managing the entire Biotechnology Manufacturing Operations for commercial products derived from core platform technologies (Yeast, E. coli, Mammalian cells) for Human r-DNA derived Insulin, Epo, and Insulin Glargine. Dr. Kumar was an Executive Director, Novavax Inc. USA, Technical (Analytical development, Product development) and Quality Operations, responsible for corporate strategies and functional leadership. Prior to that Dr. Kumar worked as Dy. Director in Sanofi-Aventis and responsible for 10 licensed products methods, process development, validation & CMC. Dr. Kumar brings strong strategic corporate management, project, product, portfolio, business and communication and prioritization skills. He published over 51 peer-reviewed manuscripts and abstracts, presented 100 international and national lectures. Dr. Kumar is member of numerous professional Organizations and has patents on novel technology.

Niranjan M. ...

smi-online.co.uk [cached]

Niranjan M. Kumar Niranjan M. Kumar, President, ABS Inc. USA

Similar Profiles

Other People with this Name

Other people with the name Kumar

Vikram Kumar
Davidson College

Sanjeev Kumar
Seagrass Boutique Hospitality Group

G. Kumar
Hinduja Leyland Finance Ltd

Mandip Kumar
Cartwright King

Prakash Kumar

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory